The Latest Breaking News from Leqembi

Alzheimer's Treatment Is Entering a New Era — Here Is Everything That Has Changed in 2026

Leqembi and Kisunla are slowing Alzheimer's decline by 27-35% in early-stage patients. The 2026 drug pipeline has 158 candidates in 192 trials. Prevention trials are beginning. Here's the full update.

Medical Daily · Jun 11

World Alzheimer's Day: Is France's once world-renowned care falling behind?

France was once a pioneer of Alzheimer's care, but as the number of sufferers continues to rise and budgets are cut, the country is now struggling to tackle what is one of the world's most pressing public health crises.

Radio France Internationale · Sep 21, 2025

FDA Tightens Safety Guidelines For Biogen Leqembi Alzheimer's Therapy

The U.S. Food and Drug Administration (FDA) stated on Thursday that it is requiring an additional MRI scan for Alzheimer's patients receiving Leqembi (lecanemab), citing safety concerns over a rare but potentially fatal side effect.

Benzinga · Aug 29, 2025

FDA approves new Alzheimer's drug

Leqembi has proven to slow the progression of the disease, while others only target its symptoms

Salon · Jul 6, 2023

FDA approves Leqembi, first drug to slow Alzheimer’s progression

Eisai and Biogen's Leqembi is the first drug to slow Alzheimer's progression to receive full FDA approval.

Axios · Jul 6, 2023

Alzheimer's drug Leqembi gets full FDA approval. Medicare coverage will likely follow

The first drug found to slow the progression of Alzheimer's disease has been granted full approval by the Food and Drug Administration.

WEKU · Jul 6, 2023

FDA grants full approval to new Alzheimer’s drug - Roll Call

The drug Leqembi targets plaque buildup in the brain, and it is approved for people in the early stages of the disease.

Roll Call · Jul 6, 2023

Expected Alzheimer’s drug approval signals new era in treatment - Roll Call

The Alzheimer's drug's approval would trigger broader access under Medicare, but critics say it shouldn't be on the market at all.

Roll Call · Jul 6, 2023

Does Medicare pay for Alzheimer's drugs? The answer is complicated and changing

There are no drugs or treatments to cure Alzheimer’s disease, but emerging drugs may slow disease progression.

Fortune · Jun 15, 2023

FDA advisers say new Alzheimer’s drug lecanemab slows cognitive decline

Panel’s opinion could pave way for full regulatory approval next month for treatment of disease that affects 6.5m Americans

The Guardian - US · Jun 10, 2023